Trials / Terminated
TerminatedNCT02325063
Evaluation of Three Types of Injection for the Treatment of Lateral Epicondylalgia
Leukocyte and Platelet Rich Plasma Versus Type A Botulinum Toxin Versus Glucocorticoids for the Treatment of Lateral Epicondylalgia: a Randomized, Multicenter, Double-blind, Therapeutic Trial With Three Parallel Arms
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nīmes · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to compare the evolution of pain profiles among patients suffering from lateral epicondyalgia (tennis elbow) following three types of treatment: PRP-L injection versus type A botulinum toxin injection versus corticoid injection.
Detailed description
The secondary objectives are to compare the following among the three groups: A- The global efficacy of each treatment defined by a minimum reduction of 25% in average pain over the last 24 hours between 0 and 6 months. B- The evolution of average pain over the last 24 hours between 0 and each different time frame (3 weeks, 6 weeks, 3 months and 6 months). C- The evolution of maximum pain scores using nocturnal post-effort (Jamar grip test) visual analog scales (VAS) between day 0, 3 weeks, 6 weeks, 3 months and 6 months. D- The perception of change on the Patient's Global Impression of Change score (PGIC) at 3 and 6 months E- The evolution of PRTEE scores at 0, 3 and 6 months F- Adverse events at 3 weeks, 6 weeks, 3 months and 6 months. G - Quality of life and utility via the SF-12 at 3 and 6 months. H- The consumption of analgesics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PRP-L Injection | Patients will be treated with an injection of leukocyte and platelet rich plasma. |
| DRUG | Botox injection | Patients will be treated with an injection of Type A Botulinum toxin. |
| DRUG | Corticoid injection | Patients will be treated with an injection of Corticoids. |
Timeline
- Start date
- 2015-12-17
- Primary completion
- 2017-05-02
- Completion
- 2017-05-02
- First posted
- 2014-12-24
- Last updated
- 2025-12-10
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02325063. Inclusion in this directory is not an endorsement.